Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome).

PURPOSE Deficiencies in enzymes involved in proteoglycan (PG) turnover underlie a number of rare mucopolysaccharidoses (MPS), investigations of which can considerably aid understanding of the roles of PGs in corneal matrix biology. Here, the authors analyze novel pathologic changes in MPS VII (Sly syndrome) to determine the nature of PG-collagen associations in stromal ultrastructure. METHODS Transmission electron microscopy and electron tomography were used to investigate PG-collagen architectures and interactions in a cornea obtained at keratoplasty from a 22-year-old man with MPS VII, which was caused by a compound heterozygous mutation in the GUSB gene. RESULTS Transmission electron microscopy showed atypical morphology of the epithelial basement membrane and Bowman's layer in MPS VII. Keratocytes were packed with cytoplasmic vacuoles containing abnormal glycosaminoglycan (GAG) material, and collagen fibrils were thinner than in normal cornea and varied considerably throughout anterior (14-32 nm), mid (13-42 nm), and posterior (17-39 nm) regions of the MPS VII stroma. PGs viewed in three dimensions were striking in appearance in that they were significantly larger than PGs in normal cornea and formed highly extended linkages with multiple collagen fibrils. CONCLUSIONS Cellular changes in the MPS VII cornea resemble those in other MPS. However, the wide range of collagen fibril diameters throughout the stroma and the extensive matrix presence of supranormal-sized PG structures appear to be unique features of this disorder. The findings suggest that the accumulation of stromal chondroitin-, dermatan-, and heparan-sulfate glycosaminoglycans in the absence of β-glucuronidase-mediated degradation can modulate collagen fibrillogenesis.

[1]  K. Nishida,et al.  Electron tomography reveals multiple self-association of chondroitin sulphate/dermatan sulphate proteoglycans in Chst5-null mouse corneas. , 2011, Journal of structural biology.

[2]  K. Ponder,et al.  Gene therapy for ocular problems in mucopolysaccharidosis: an experimental and promising approach with benefits in animal models – a review , 2010 .

[3]  J. Jester,et al.  Genetic basis of corneal diseases and the role of keratocytes in corneal transparency – a review , 2010 .

[4]  H. Dua,et al.  Application of (lamellar) keratoplasty and limbal stem cell transplantation for corneal clouding in the mucopolysaccharidoses – a review , 2010 .

[5]  A. Tormene,et al.  Ocular manifestations in the mucopolysaccharidoses – a review , 2010 .

[6]  A. Quantock,et al.  Elucidation of Collagen-Proteoglycan Interactions in the Mouse Corneal Stroma by Electron Tomography , 2010 .

[7]  A. Quantock,et al.  Structural interactions between collagen and proteoglycans are elucidated by three-dimensional electron tomography of bovine cornea. , 2010, Structure.

[8]  R. Iozzo,et al.  Collagen fibril organization in the pregnant endometrium of decorin‐deficient mice , 2010, Journal of anatomy.

[9]  W. Sly,et al.  Human Mutation MUTATION UPDATE Mutations and Polymorphisms in GUSB Gene in Mucopolysaccharidosis VII (Sly Syndrome) , 2009 .

[10]  A. Quantock,et al.  The architecture of the cornea and structural basis of its transparency. , 2009, Advances in protein chemistry and structural biology.

[11]  L. Schaefer,et al.  Proteoglycans: from structural compounds to signaling molecules , 2009, Cell and Tissue Research.

[12]  J. Biswas,et al.  Ocular manifestation of storage diseases , 2008, Current opinion in ophthalmology.

[13]  W. Sly,et al.  Infused Fc-tagged β-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice , 2008, Proceedings of the National Academy of Sciences.

[14]  Satoshi Kawasaki,et al.  Small-angle fibre diffraction studies of corneal matrix structure: a depth-profiled investigation of the human eye-bank cornea , 2007 .

[15]  Philip Lewis,et al.  Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase , 2006, Proceedings of the National Academy of Sciences.

[16]  I. Date,et al.  Encapsulation cell therapy for mucopolysaccharidosis type VII using genetically engineered immortalized human amniotic epithelial cells. , 2006, The Tohoku journal of experimental medicine.

[17]  S. Biswas,et al.  Mucopolysaccharidoses and the eye. , 2006, Survey of ophthalmology.

[18]  刘金明,et al.  IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .

[19]  Ashutosh Kumar Singh,et al.  Morquio syndrome: electron microscopic findings , 2005, British Journal of Ophthalmology.

[20]  K. Fukuda,et al.  Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. , 2005, Investigative ophthalmology & visual science.

[21]  M. Iwamoto,et al.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A) , 1990, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  Y. Cheng,et al.  Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis , 2003, Journal of perinatal medicine.

[23]  Sanford M. Simon,et al.  Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells , 2002, The Journal of cell biology.

[24]  Marian F Young,et al.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. , 2002, Glycobiology.

[25]  S. Akhtar,et al.  Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea , 2002, The British journal of ophthalmology.

[26]  P. Roughley,et al.  Catabolism of Proteoglycans , 2000 .

[27]  P. Neame,et al.  Small Leucine-Rich Proteoglycans , 2000 .

[28]  B. Glasgow,et al.  Corneal transplantation in a patient with mucopolysaccharidosis type VII (Sly disease) , 2000, Ophthalmic genetics.

[29]  W. Sly,et al.  Enzyme Replacement in Murine Mucopolysaccharidosis Type VII: Neuronal and Glial Response to β-Glucuronidase Requires Early Initiation of Enzyme Replacement Therapy , 1999, Pediatric Research.

[30]  J. Alroy,et al.  Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI. , 1999, Experimental eye research.

[31]  F. Reinholt,et al.  Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.

[32]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[33]  K. Meek,et al.  X‐Ray Diffraction and Transmission Electron Microscopy of Morquio Syndrome Type A Cornea: A Structural Analysis , 1997, Cornea.

[34]  R. Vervoort,et al.  Molecular analysis of the ß-glucuronidase gene: novel mutations in mucopolysaccharidosis type VII and heterogeneity of the polyadenylation region , 1997, Human Genetics.

[35]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[36]  A. Vellodi,et al.  Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. , 1996, Experimental eye research.

[37]  W. Sly,et al.  Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. , 1996, American Journal of Human Genetics.

[38]  G. Aguirre,et al.  Corneal Endothelium in Mucopolysaccharide Storage Disorders: Morphologic Studies in Animal Models , 1996, Cornea.

[39]  A. Quantock,et al.  Scheie's syndrome: the architecture of corneal collagen and distribution of corneal proteoglycans. , 1993, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[40]  W. Sly,et al.  Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse. , 1993, Experimental eye research.

[41]  M. Sands,et al.  Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer , 1992, Nature.

[42]  W. Nyhan,et al.  A new quantitative assay for glycosaminoglycans. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[43]  W. Sly,et al.  Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. , 1991, Blood.

[44]  E. Traboulsi,et al.  Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. , 1990, Ophthalmology.

[45]  H. Kresse,et al.  Degradation of endocytosed dermatan sulfate proteoglycan in human fibroblasts. , 1988, The Journal of biological chemistry.

[46]  R. Gitzelmann,et al.  Unusually mild course of beta-glucuronidase deficiency in two brothers (mucopolysaccharidosis VII). , 1978, Helvetica paediatrica acta.

[47]  Lorincz Ae The mucopolysaccharidoses: advances in understanding and treatment. , 1978, Pediatric annals.

[48]  A. E. Lorincz The mucopolysaccharidoses: advances in understanding and treatment. , 1978, Pediatric annals.

[49]  W. Sly,et al.  Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. , 1973, The Journal of pediatrics.

[50]  R. Giugliani,et al.  The mucopolysaccharidoses. , 1976, Journal of medical genetics.